|
Mylan Launches First Bioequivalent Alternative to Combination Asthma Therapy …
MarketWatch Mylan President Rajiv Malik said, "Mylan is excited to be the first company to offer adult asthma patients in the UK the generic version of Seretide Evohaler, delivering on our mission to increase access to high quality medicine. Sirdupla represents a … |
View full post on asthma – Google News